Hoffman Robert E. - Insider Non-Derivative Transactions at Kintara Therapeutics, Inc. (KTRA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 1, 2023, Hoffman Robert E.'s relationship to Kintara Therapeutics, Inc. (KTRA) is Director,Officer (President, CEO, and CFO), and currently has 68,902 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KTRA insiders.
Data Source: SEC.
Hoffman Robert E. - Insider Non-Derivative Transactions at KTRA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 2, 2023 | Acquisition -- (Common Stock, par value $0.001 per share) | 59800 | 0 | 68902 |